Upcoming webinar, with introduction by Dr. Gordon

Who needs thyroid? That issue will be discussed by high level academicians who are lab experts who are discussing some new ways to evaluate thyroid function. Of course the book by Mark Starr MD called Hypothyroidism Type Two will not be on this agenda but these are some enlighten experts who see that current thyroid testing leaves much to be desired. 

Garry F. Gordon MD,DO,MD(H)
President, Gordon Research Institute
www.gordonresearch.com

Link: http://www.aacc.org/events/meetings/Pages/6201.aspx

Excerpt:

Approximately 20 million Americans now suffer from some form of thyroid disease, but experts estimate that about 13 million of them have not been diagnosed. With so many affected by a dysfunctional thyroid gland, thyroid function testing is becoming increasingly important to support both the diagnosis and management of thyroid disease. Unfortunately, controversy still exists concerning the upper limit of the TSH reference range and there is still confusion over when to use other thyroid immunoassays in the management of patients suspected of thyroid disease. Additionally, tandem mass spectrometry is rapidly emerging as a technology that could challenge labs’ reliance on traditional immunoassays for T4 and FT4. 

During this interactive webinar, you will hear the most up-to-date information on a variety of contemporary issues related to testing for thyroid disease.